×
About 2,689 results

ALLMedicine™ Partial Thromboplastin Time Center

Research & Reviews  1,331 results

Systematic Review of Machine Learning Models for Personalised Dosing of Heparin.
https://doi.org/10.1111/bcp.14852
British Journal of Clinical Pharmacology; Falconer N, Abdel-Hafez A et. al.

Apr 9th, 2021 - To identify and critically appraise studies of prediction models, developed using machine learning (ML) methods, for determining the optimal dosing of unfractionated heparin (UFH). Embase, PubMed, CINAHL, Web of Science, International Pharmaceutic...

Activated Partial Thromboplastin Time Versus Anti-Factor Xa Monitoring of Heparin Antic...
https://doi.org/10.1097/MAT.0000000000001246
ASAIO Journal (American Society for Artificial Internal O... Kulig CE, Schomer KJ et. al.

Mar 26th, 2021 - The preferred assay for measuring and adjusting unfractionated heparin (UFH) infusion to achieve optimal outcomes during extracorporeal membrane oxygenation (ECMO) is not well established. This retrospective cohort study explored safety and effica...

Pre-analytical variables in haemostasis: Findings from the United Kingdom National Exte...
https://doi.org/10.1111/ijlh.13468
International Journal of Laboratory Hematology; Brown L, Jennings I et. al.

Feb 19th, 2021 - Haemolysis is considered one of the major contributors of nonconformities and sample rejection in coagulation testing. Two lyophilized plasmas were distributed to 800 centres registered for prothrombin time (PT), activated partial thromboplastin t...

The Evaluation of APTT Reagents in Reference Plasma, Recombinant FVIII Products; Kovalt...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900842
Clinical and Applied Thrombosis/hemostasis : Official Jou... Wada H, Shiraki K et. al.

Feb 19th, 2021 - The FVIII activity in patients treated with several extended half-life FVIII (EHL-FVIII) agents different when various activated partial thromboplastin time (APTT) reagents were used. The present study examined the difference in clot waveform anal...

Life-threatening bleeding in a patient with pemphigoid-induced acquired hemophilia A an...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837823
Medicine Ma H, Chang H

Feb 6th, 2021 - Acquired hemophilia A (AHA) is a rare bleeding disorder with prolonged activated partial thromboplastin time (aPTT). Severe hemorrhage may occur, especially in refractory AHA. We reported a 63-year-old man who suffered from life-threatening bleedi...

see more →

Clinicaltrials.gov  1,341 results

Systematic Review of Machine Learning Models for Personalised Dosing of Heparin.
https://doi.org/10.1111/bcp.14852
British Journal of Clinical Pharmacology; Falconer N, Abdel-Hafez A et. al.

Apr 9th, 2021 - To identify and critically appraise studies of prediction models, developed using machine learning (ML) methods, for determining the optimal dosing of unfractionated heparin (UFH). Embase, PubMed, CINAHL, Web of Science, International Pharmaceutic...

Activated Partial Thromboplastin Time Versus Anti-Factor Xa Monitoring of Heparin Antic...
https://doi.org/10.1097/MAT.0000000000001246
ASAIO Journal (American Society for Artificial Internal O... Kulig CE, Schomer KJ et. al.

Mar 26th, 2021 - The preferred assay for measuring and adjusting unfractionated heparin (UFH) infusion to achieve optimal outcomes during extracorporeal membrane oxygenation (ECMO) is not well established. This retrospective cohort study explored safety and effica...

Pre-analytical variables in haemostasis: Findings from the United Kingdom National Exte...
https://doi.org/10.1111/ijlh.13468
International Journal of Laboratory Hematology; Brown L, Jennings I et. al.

Feb 19th, 2021 - Haemolysis is considered one of the major contributors of nonconformities and sample rejection in coagulation testing. Two lyophilized plasmas were distributed to 800 centres registered for prothrombin time (PT), activated partial thromboplastin t...

The Evaluation of APTT Reagents in Reference Plasma, Recombinant FVIII Products; Kovalt...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900842
Clinical and Applied Thrombosis/hemostasis : Official Jou... Wada H, Shiraki K et. al.

Feb 19th, 2021 - The FVIII activity in patients treated with several extended half-life FVIII (EHL-FVIII) agents different when various activated partial thromboplastin time (APTT) reagents were used. The present study examined the difference in clot waveform anal...

Life-threatening bleeding in a patient with pemphigoid-induced acquired hemophilia A an...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837823
Medicine Ma H, Chang H

Feb 6th, 2021 - Acquired hemophilia A (AHA) is a rare bleeding disorder with prolonged activated partial thromboplastin time (aPTT). Severe hemorrhage may occur, especially in refractory AHA. We reported a 63-year-old man who suffered from life-threatening bleedi...

see more →

News  17 results

Von Willebrand Disease: Approach to Diagnosis and Management
https://www.mdedge.com/hematology-oncology/article/160759/bleeding-disorders/von-willebrand-disease-approach-diagnosis-and/page/0/2

Mar 27th, 2018 - Type 3 Type 3 VWD is defined by a virtual absence of VWF. The inheritance of type 3 VWD has often been reported as autosomal recessive.

VIDEO: Point-of-care microsensor prototype beats conventional coagulopathy tests
https://www.mdedge.com/emergencymedicine/article/119593/bleeding-disorders/video-point-care-microsensor-prototype-beats
Amy Karon

Dec 6th, 2016 - SAN DIEGO – Using less than a drop of blood, a portable microsensor provided a comprehensive coagulation profile in minutes and perfectly distinguished various coagulopathies from normal blood samples – handily beating both activated partial throm.

Microsensor perfectly distinguished coagulopathy patients from controls
https://www.mdedge.com/emergencymedicine/article/119430/bleeding-disorders/microsensor-perfectly-distinguished-coagulopathy
Amy Karon

Dec 5th, 2016 - SAN DIEGO – Using less than a drop of blood, a portable microsensor provided a comprehensive coagulation profile in less than 15 minutes and perfectly distinguished various coagulopathies from normal blood samples – handily beating the results wit.

Implementing a New Protocol for Heparin Anticoagulation
https://www.mdedge.com/fedprac/article/113332/oncology/implementing-new-protocol-heparin-anticoagulation
Milner B, Stavrou E et. al.

Sep 2nd, 2016 - Purpose: Intravenous unfractionated heparin (UFH) remains an important anticoagulation (AC) agent, particularly in the inpatient setting. Historically, the activated partial thromboplastin time (aPTT) has been the primary laboratory test used to m.

Factor VIII–mimetic antibody effective in hemophilia A
https://www.mdedge.com/hematology-oncology/article/107914/bleeding-disorders/factor-viii-mimetic-antibody-effective
Jennifer Shepphird

Apr 7th, 2016 - The bispecific factor VIII–mimetic antibody ACE910 has a longer half-life than current hemophilia A treatments, potentially offering a more convenient once-weekly, subcutaneous injection, based on a study published in Blood. In a phase I study, AC.

see more →